TreeWAS – Variant ID: rs7588550

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K31.7 Polyp of stomach and duodenum	0.000	0.956	0.044
M19.91 Arthrosis, unspecified (Shoulder region)	0.000	0.976	0.024
K31 Other diseases of stomach and duodenum	0.000	0.981	0.019
M19.9 Arthrosis, unspecified	0.000	0.981	0.019
M19.94 Arthrosis, unspecified (Hand)	0.000	0.983	0.017
K31.8 Other specified diseases of stomach and duodenum	0.000	0.983	0.017
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.000	0.983	0.016
M19.99 Arthrosis, unspecified (Site unspecified)	0.000	0.984	0.016
K31.5 Obstruction of duodenum	0.000	0.984	0.016
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.985	0.015
M19 Other arthrosis	0.000	0.985	0.015
K31.0 Acute dilatation of stomach	0.000	0.986	0.014
K31.2 Hourglass stricture and stenosis of stomach	0.000	0.986	0.014
K31.3 Pylorospasm, not elsewhere classified	0.000	0.986	0.014
K31.6 Fistula of stomach and duodenum	0.000	0.986	0.013
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.987	0.013
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.987	0.013
K31.4 Gastric diverticulum	0.000	0.987	0.012
M19.92 Arthrosis, unspecified (Upper arm)	0.000	0.987	0.012
M19.98 Arthrosis, unspecified (Other)	0.000	0.988	0.012
M19.1 Posttraumatic arthrosis of other joints	0.000	0.988	0.012
M19.97 Arthrosis, unspecified (Ankle and foot)	0.000	0.988	0.012
M19.0 Primary arthrosis of other joints	0.000	0.988	0.012
M19.2 Other secondary arthrosis	0.000	0.988	0.012
K31.1 Adult hypertrophic pyloric stenosis	0.000	0.989	0.011
M19.8 Other specified arthrosis	0.000	0.989	0.011
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.989	0.011
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.990	0.010
M19.96 Arthrosis, unspecified-Lower leg	0.000	0.990	0.010
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.990	0.010
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.990	0.010
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.990	0.009
M19.27 Other secondary arthrosis (Ankle and foot)	0.000	0.990	0.009
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.991	0.009
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.000	0.991	0.009
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.000	0.991	0.009
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.000	0.991	0.009
M19.08 Primary arthrosis of other joints (Other)	0.000	0.991	0.009
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.000	0.991	0.009
M19.18 Post-traumatic arthrosis of other joints (Other)	0.000	0.991	0.009
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.000	0.991	0.009
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.000	0.991	0.009
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.991	0.009
M19.23 Other secondary arthrosis (Forearm)	0.000	0.991	0.009
M19.29 Other secondary arthrosis (Site unspecified)	0.000	0.991	0.008
M19.28 Other secondary arthrosis (Other)	0.000	0.991	0.008
M19.26 Other secondary arthrosis of other joints-Lower leg	0.000	0.991	0.008
M19.25 Other secondary arthrosis (Pelvic region and thigh)	0.000	0.991	0.008
M19.24 Other secondary arthrosis (Hand)	0.000	0.991	0.008
M19.22 Other secondary arthrosis (Upper arm)	0.000	0.991	0.008
M19.20 Other secondary arthrosis (Multiple sites)	0.000	0.991	0.008
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.000	0.991	0.008
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.991	0.008
M19.21 Other secondary arthrosis (Shoulder region)	0.000	0.991	0.008
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.000	0.992	0.008
M19.88 Other specified arthrosis (Other)	0.000	0.992	0.008
M19.84 Other specified arthrosis (Hand)	0.000	0.992	0.008
M19.89 Other specified arthrosis (Site unspecified)	0.000	0.992	0.008
M19.87 Other specified arthrosis (Ankle and foot)	0.000	0.992	0.008
M19.86 Other specified arthrosis (Lower leg)	0.000	0.992	0.008
M19.85 Other specified arthrosis (Pelvic region and thigh)	0.000	0.992	0.008
M19.83 Other specified arthrosis (Forearm)	0.000	0.992	0.008
M19.82 Other specified arthrosis (Upper arm)	0.000	0.992	0.008
M19.80 Other specified arthrosis (Multiple sites)	0.000	0.992	0.008
M19.81 Other specified arthrosis (Shoulder region)	0.000	0.992	0.008
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.992	0.007
M17.0 Primary gonarthrosis, bilateral	0.000	0.993	0.007
Y43.3 Other antineoplastic drugs	0.006	0.994	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.006	0.994	0.000
Z03.4 Observation for suspected myocardial infarction	0.006	0.994	0.000
Z35.5 Supervision of elderly primigravida	0.006	0.994	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.995	0.005
M17 Gonarthrosis [arthrosis of knee]	0.000	0.995	0.005
M17.5 Other secondary gonarthrosis	0.000	0.995	0.005
Z35 Supervision of high-risk pregnancy	0.005	0.995	0.000
H71 Cholesteatoma of middle ear	0.005	0.995	0.000
M15-M19 Arthrosis	0.000	0.995	0.005
Z35.0 Supervision of pregnancy with history of infertility	0.005	0.995	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.001	0.996	0.004
M17.3 Other posttraumatic gonarthrosis	0.000	0.996	0.004
I12.0 Hypertensive renal disease with renal failure	0.004	0.996	0.000
O36.8 Maternal care for other specified foetal problems	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.996	0.004
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.996	0.004
Z35.1 Supervision of pregnancy with history of abortive outcome	0.004	0.996	0.000
H65-H75 Diseases of middle ear and mastoid	0.004	0.996	0.000
Z35.8 Supervision of other high-risk pregnancies	0.004	0.996	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.000	0.996	0.004
K83.8 Other specified diseases of biliary tract	0.000	0.996	0.004
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.004	0.996	0.000
H66 Suppurative and unspecified otitis media	0.004	0.996	0.000
F33 Recurrent depressive disorder	0.000	0.996	0.004
H69 Other disorders of Eustachian tube	0.004	0.996	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.004	0.996	0.000
Z35.6 Supervision of very young primigravida	0.004	0.996	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.004	0.996	0.000
M15 Polyarthrosis	0.000	0.996	0.004
Z35.4 Supervision of pregnancy with grand multiparity	0.004	0.996	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.004	0.996	0.000
H66.3 Other chronic suppurative otitis media	0.004	0.996	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.000	0.996	0.003
H74 Other disorders of middle ear and mastoid	0.004	0.996	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.996	0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.000	0.996	0.004
K83 Other diseases of biliary tract	0.000	0.997	0.003
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
H69.9 Eustachian tube disorder, unspecified	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
C82.2 Large cell, follicular	0.000	0.997	0.003
N84.1 Polyp of cervix uteri	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.997	0.003
C82.3 Follicular lymphoma grade IIIa	0.000	0.997	0.003
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.997	0.003
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.997	0.003
H69.8 Other specified disorders of Eustachian tube	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
K83.0 Cholangitis	0.000	0.997	0.003
C82.6 Cutaneous follicle centre lymphoma	0.000	0.997	0.003
C82.5 Diffuse follicle centre lymphoma	0.000	0.997	0.003
M15.8 Other polyarthrosis	0.000	0.997	0.003
C82.4 Follicular lymphoma grade IIIb	0.000	0.997	0.003
H74.3 Other acquired abnormalities of ear ossicles	0.003	0.997	0.000
K83.9 Disease of biliary tract, unspecified	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
M13.94 Arthritis, unspecified (Hand)	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.000	0.997	0.003
H66.4 Suppurative otitis media, unspecified	0.003	0.997	0.000
F31 Bipolar affective disorder	0.000	0.997	0.003
M15.9 Polyarthrosis, unspecified	0.000	0.997	0.003
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.003	0.997	0.000
H67 Otitis media in diseases classified elsewhere	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
H70 Mastoiditis and related conditions	0.003	0.997	0.000
H68 Eustachian salpingitis and obstruction	0.003	0.997	0.000
R04.2 Haemoptysis	0.000	0.997	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
F31.9 Bipolar affective disorder, unspecified	0.000	0.997	0.003
H66.1 Chronic tubotympanic suppurative otitis media	0.003	0.997	0.000
K83.1 Obstruction of bile duct	0.000	0.997	0.003
H66.9 Otitis media, unspecified	0.003	0.997	0.000
H66.0 Acute suppurative otitis media	0.003	0.997	0.000
M15.2 Bouchard's nodes (with arthropathy)	0.000	0.997	0.003
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
H72 Perforation of tympanic membrane	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
M13.96 Arthritis, unspecified (Lower leg)	0.000	0.997	0.003
F33.8 Other recurrent depressive disorders	0.000	0.997	0.003
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.997	0.003
H74.8 Other specified disorders of middle ear and mastoid	0.003	0.997	0.000
N18.3 Chronic kidney disease, stage 3	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.997	0.003
H69.0 Patulous Eustachian tube	0.003	0.997	0.000
C82.0 Small cleaved cell, follicular	0.000	0.997	0.003
H74.1 Adhesive middle ear disease	0.003	0.997	0.000
F33.9 Recurrent depressive disorder, unspecified	0.000	0.997	0.003
H66.2 Chronic atticoantral suppurative otitis media	0.003	0.997	0.000
H74.2 Discontinuity and dislocation of ear ossicles	0.003	0.997	0.000
K83.4 Spasm of sphincter of Oddi	0.000	0.997	0.003
M13.9 Arthritis, unspecified	0.000	0.997	0.003
M15.0 Primary generalised (osteo)arthrosis	0.000	0.997	0.003
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.997	0.003
G91.9 Hydrocephalus, unspecified	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
H74.0 Tympanosclerosis	0.003	0.997	0.000
F30-F39 Mood [affective] disorders	0.000	0.997	0.003
K40 Inguinal hernia	0.003	0.997	0.000
M15.4 Erosive (osteo)arthrosis	0.000	0.997	0.003
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
F31.7 Bipolar affective disorder, currently in remission	0.000	0.997	0.003
M13.92 Arthritis, unspecified (Upper arm)	0.000	0.997	0.003
H73 Other disorders of tympanic membrane	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
M15.3 Secondary multiple arthrosis	0.000	0.997	0.003
K83.5 Biliary cyst	0.000	0.997	0.003
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
C92 Myeloid leukaemia	0.000	0.997	0.003
H74.9 Disorder of middle ear and mastoid, unspecified	0.003	0.997	0.000
K83.3 Fistula of bile duct	0.000	0.997	0.003
F30 Manic episode	0.000	0.997	0.003
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
F34 Persistent mood [affective] disorders	0.000	0.997	0.003
K83.2 Perforation of bile duct	0.000	0.997	0.003
C95 Leukaemia of unspecified cell type	0.000	0.997	0.003
M15.99 Polyosteoarthritis, unspecified	0.000	0.997	0.002
H72.0 Central perforation of tympanic membrane	0.003	0.997	0.000
H74.4 Polyp of middle ear	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
N18.5 Chronic kidney disease, stage 5	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.997	0.003
Y42.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.997	0.003
F34.1 Dysthymia	0.000	0.997	0.002
H72.8 Other perforations of tympanic membrane	0.002	0.997	0.000
Y42.4 Oral contraceptives	0.002	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.997	0.000
Y52.1 Calcium-channel blockers	0.002	0.997	0.000
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.002
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.997	0.002
H02.4 Ptosis of eyelid	0.000	0.997	0.003
L40.5 Arthropathic psoriasis	0.000	0.997	0.003
M07.3 Other psoriatic arthropathies	0.000	0.997	0.003
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
H70.9 Mastoiditis, unspecified	0.002	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.997	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
C81 Hodgkin's disease	0.000	0.997	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.997	0.000
F30.9 Manic episode, unspecified	0.000	0.997	0.002
H67.8 Otitis media in other diseases classified elsewhere	0.002	0.997	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.002	0.997	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.002	0.997	0.000
H70.8 Other mastoiditis and related conditions	0.002	0.997	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.002	0.997	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
Y45.4 Antirheumatics	0.002	0.997	0.000
Y52.7 Peripheral vasodilators	0.002	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.997	0.000
H68.0 Eustachian salpingitis	0.002	0.997	0.000
H70.2 Petrositis	0.002	0.997	0.000
M15.1 Heberden's nodes (with arthropathy)	0.000	0.997	0.002
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.002
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.997	0.002
O36 Maternal care for other known or suspected foetal problems	0.002	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.997	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.002
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.998	0.002
H68.1 Obstruction of Eustachian tube	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
F31.8 Other bipolar affective disorders	0.000	0.998	0.002
H70.0 Acute mastoiditis	0.002	0.998	0.000
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C93 Monocytic leukaemia	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
H70.1 Chronic mastoiditis	0.002	0.998	0.000
O63.0 Prolonged first stage (of labour)	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.000	0.998	0.002
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
M15.00 Primary generalized (osteo)arthrosis, Multiple sites	0.000	0.998	0.002
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
F30.0 Hypomania	0.000	0.998	0.002
C94 Other leukaemias of specified cell type	0.000	0.998	0.002
G91 Hydrocephalus	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
C83.0 Small cell (diffuse)	0.000	0.998	0.002
C95.0 Acute leukaemia of unspecified cell type	0.000	0.998	0.002
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.998	0.002
H72.1 Attic perforation of tympanic membrane	0.002	0.998	0.000
K40.1 Bilateral inguinal hernia, with gangrene	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.998	0.002
Y58 Bacterial vaccines	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
C95.9 Leukaemia, unspecified	0.000	0.998	0.002
H72.2 Other marginal perforations of tympanic membrane	0.002	0.998	0.000
H73.0 Acute myringitis	0.002	0.998	0.000
N18.9 Chronic renal failure, unspecified	0.002	0.998	0.000
O47.9 False labour, unspecified	0.002	0.998	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
O47 False labour	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
F30.2 Mania with psychotic symptoms	0.000	0.998	0.002
H02.3 Blepharochalasis	0.000	0.998	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
O36.3 Maternal care for signs of foetal hypoxia	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.000	0.998	0.002
F38 Other mood [affective] disorders	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
M13.93 Arthritis, unspecified (Forearm)	0.000	0.998	0.002
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.998	0.002
F30.8 Other manic episodes	0.000	0.998	0.002
F34.0 Cyclothymia	0.000	0.998	0.002
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
N18 Chronic renal failure	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
C95.7 Other leukaemia of unspecified cell type	0.000	0.998	0.002
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.998	0.002
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.998	0.002
F34.8 Other persistent mood [affective] disorders	0.000	0.998	0.002
H73.1 Chronic myringitis	0.002	0.998	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.998	0.002
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.998	0.002
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
G91.2 Normal-pressure hydrocephalus	0.002	0.998	0.000
C81.1 Nodular sclerosis	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
O36.5 Maternal care for poor foetal growth	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.002
C81.0 Lymphocytic predominance	0.000	0.998	0.002
C83.5 Lymphoblastic (diffuse)	0.000	0.998	0.002
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.002	0.998	0.000
H02 Other disorders of eyelid	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
F30.1 Mania without psychotic symptoms	0.000	0.998	0.002
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.000	0.998	0.002
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
C83.2 Mixed small and large cell (diffuse)	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.002
Y41.0 Sulphonamides	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.002	0.998	0.000
F39 Unspecified mood [affective] disorder	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Z36 Antenatal screening	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.998	0.002
C81.3 Lymphocytic depletion	0.000	0.998	0.002
G91.0 Communicating hydrocephalus	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.998	0.002
C83.4 Immunoblastic (diffuse)	0.000	0.998	0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.998	0.002
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.998	0.002
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.998	0.002
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.998	0.002
H72.9 Perforation of tympanic membrane, unspecified	0.002	0.998	0.000
O36.2 Maternal care for hydrops foetalis	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Z33 Pregnant state, incidental	0.002	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
G91.8 Other hydrocephalus	0.002	0.998	0.000
N87.1 Moderate cervical dysplasia	0.000	0.998	0.002
Y44.2 Anticoagulants	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.000	0.998	0.002
C93.7 Other monocytic leukaemia	0.000	0.998	0.002
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.998	0.002
C93.2 Subacute monocytic leukaemia	0.000	0.998	0.002
C93.0 Acute monocytic leukaemia	0.000	0.998	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.998	0.002
C96.8 Histiocytic sarcoma	0.000	0.998	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.998	0.002
C96.3 True histiocytic lymphoma	0.000	0.998	0.002
C96.2 Malignant mast cell tumour	0.000	0.998	0.002
C96.1 Malignant histiocytosis	0.000	0.998	0.002
C96.0 Letterer-Siwe disease	0.000	0.998	0.002
M17.1 Other primary gonarthrosis	0.000	0.998	0.002
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.000	0.998	0.002
H02.0 Entropion and trichiasis of eyelid	0.000	0.998	0.002
L40.0 Psoriasis vulgaris	0.000	0.998	0.002
O36.4 Maternal care for intra-uterine death	0.002	0.998	0.000
O36.1 Maternal care for other isoimmunisation	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
M13 Other arthritis	0.000	0.998	0.002
C81.7 Other Hodgkin's disease	0.000	0.998	0.002
C91.9 Lymphoid leukaemia, unspecified	0.000	0.998	0.002
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.998	0.002
C91.7 Other lymphoid leukaemia	0.000	0.998	0.002
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.998	0.002
C91.3 Prolymphocytic leukaemia	0.000	0.998	0.002
C91.2 Subacute lymphocytic leukaemia	0.000	0.998	0.002
H65.1 Other acute nonsuppurative otitis media	0.002	0.998	0.000
K63.5 Polyp of colon	0.000	0.998	0.002
N43.3 Hydrocele, unspecified	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
M07 Psoriatic and enteropathic arthropathies	0.000	0.998	0.002
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.000	0.998	0.002
H02.1 Ectropion of eyelid	0.000	0.998	0.002
I24.8 Other forms of acute ischaemic heart disease	0.002	0.998	0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
C81.2 Mixed cellularity	0.000	0.998	0.002
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
C94.7 Other specified leukaemias	0.000	0.998	0.002
C94.5 Acute myelofibrosis	0.000	0.998	0.002
C94.3 Mast cell leukaemia	0.000	0.998	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.998	0.002
C94.1 Chronic erythraemia	0.000	0.998	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.998	0.002
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
M13.98 Arthritis, unspecified (Other)	0.000	0.998	0.002
G91.3 Posttraumatic hydrocephalus, unspecified	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
M18 Arthrosis of first carpometacarpal joint	0.000	0.998	0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
G91.1 Obstructive hydrocephalus	0.002	0.998	0.000
N18.0 End-stage renal disease	0.002	0.998	0.000
O36.6 Maternal care for excessive foetal growth	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations